- increased circulating free fatty acids level / IMPC
- increased mean platelet volume / IMPC
- decreased circulating triglyceride level / IMPC
- increased circulating alanine transaminase level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- thrombocytopenia / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating creatinine level / IMPC
- increased circulating amylase level / IMPC
- increased red blood cell distribution width / IMPC
- decreased circulating fructosamine level / IMPC
C57BL/6N-Tbc1d22atm1b(KOMP)Wtsi/WtsiCnbc
Status | Available to order |
EMMA ID | EM:14236 |
International strain name | C57BL/6N-Tbc1d22atm1b(KOMP)Wtsi/WtsiCnbc |
Alternative name | EPD0807_1_A05 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Tbc1d22atm1b(KOMP)Wtsi |
Gene/Transgene symbol | Tbc1d22a |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0807_1_A05. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using a cell permeable HTN-Cre as described in doi:10.1007/s11248-013-9764-x. Click here for more information on KOMP final vectors. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Animals used for archiving | heterozygous C57BL/6N |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- thrombocytopenia / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating alanine transaminase level / IMPC
- increased red blood cell distribution width / IMPC
- increased mean platelet volume / IMPC
- increased circulating free fatty acids level / IMPC
- decreased circulating fructosamine level / IMPC
- increased circulating creatinine level / IMPC
- increased circulating amylase level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased circulating triglyceride level / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).